An interventional study of K-Move/K-Push assessment system in Spasticity, Hemiparesis and Upper Extremity Spasticity, sponsored by University Hospital, Montpellier. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Muscle Spasticity with a site in France — 8 open to participants now, 8 under way, none of them phase 3. Muscle Spasticity · France.
Among the 42 studies in Muscle Spasticity with a site in France, this one is the 18th largest by planned enrollment of the 34 interventional ones that give a count, is the only one that started in 2027, is one of 26 with no phase, and was the 40th registered.
626 studies on the registry are indexed under Muscle Spasticity; 131 are open to participants now.
Browse Muscle Spasticity studies →8 of the 42 studies in Muscle Spasticity with a site in France are open now. Recruiting first, the newest first:
Poitiers University Hospital · Sites in France
Ages 18+
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Ages 3–17
Institut De La Colonne Vertebrale Et Des Neurosciences · Sites in France
Ages 5–12
Ipsen · Sites in France, United States, Austria and 11 more countries
Ages 18–70
Aix Marseille Université · Sites in France
Ages 18–80
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 88 Muscle Spasticity studies recruiting now, 29 (33%) set no upper age limit and 47 (53%) stop at 75 or younger; 34 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 4 · Phase 4 2
First in 2004; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is above the median of 36 across 476 interventional studies indexed under Muscle Spasticity.
Median enrollment 41 across the 34 interventional studies, 339 across the 8 observational. Of the 29 that completed or were terminated, 2 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 42 have an industry lead sponsor. The 10 most frequent:
University Hospital, Montpellier is the lead sponsor of 1,264 studies on the registry; 226 are open to participants now.
University Hospital, Montpellier has 2 studies filed under Muscle Spasticity — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 42 studies in Muscle Spasticity with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
SSpasticity is a common motor disorder following central nervous system injury, characterized by a velocity-dependent increase in muscle tone. It affects diverse populations, including patients with stroke, spinal cord injury, multiple sclerosis, or cerebral palsy, and leads to significant functional, pain-related, and medico-economic consequences.
Clinical assessment currently relies on the Modified Tardieu Scale (MTS) and the Modified Ashworth Scale (MAS), whose main limitations are low inter- and intra-rater reproducibility and subjective quantification. Coupling inertial measurement units (IMU) with a portable dynamometer represents a promising instrumental approach to overcome these limitations.
The hypothesis of this pilot clinical investigation is that instrumental measurement combining a portable dynamometer and inertial sensors would achieve satisfactory inter- and intra-rater reproducibility for the assessment of elbow flexor spasticity in patients with unilateral spastic paresis, thereby offering a reliable and objective alternative to current clinical scales.
This project proposes an instrumental assessment of upper-limb spasticity simultaneously combining kinematic measurement (angle, angular velocity) via two K-Move inertial sensors and measurement of resistance force via the K-Push dynamometer (Kinvent, Montpellier), which can easily be used during consultations or at the patient's bedside. This clinical investigation will secondarily assess the feasibility of a kinematic analysis based exclusively on videos acquired by tablet during the instrumental assessment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults with unilateral spastic paresis undergoing standardized clinical and instrumental assessment of elbow flexor spasticity using inertial sensors (K-Move), a handheld dynamometer (K-Push), and the Modified Tardieu Scale. Measurements are repeated to evaluate inter-rater and intra-rater reproducibility.
Device: K-Move/K-Push assessment system
Instrumented assessment of elbow flexor spasticity using two wearable inertial sensors (K-Move) synchronized with a handheld dynamometer (K-Push). The system simultaneously records joint angle, angular velocity, and resistance force during passive elbow movements. Measurements are compared with the Modified Tardieu Scale and repeated to assess inter-rater and intra-rater reproducibility.
Inter-rater and intra-rater reproducibility of instrumental measurement for elbow flexor spasticity assessment
Reproducibility of biomechanical parameters obtained from the instrumental measurement combining two inertial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast). Parameters include total elbow extension range of motion (in degrees), mean stretch velocity (in meters per second, m/s), angle of onset of spasticity (in degrees), referred to as the "catch", maximum resistance force measured by the dynamometer (in Newtons), mean resistance force measured by the dynamometer (in Newtons) over the entire movement, and extent of spastic resistance defined as the range of motion over which the resistance persists (in degrees). Inter-rater reproducibility will be assessed between two independent raters on Day 1, and intra-rater reproducibility will be assessed by repeated measurements performed by the same rater between Day 1 and Day 2.
Time frame: Day 1 and Day 2
Difference in total elbow range of motion between the affected and unaffected upper limbs
Comparison of the total elbow extension range of motion (in degrees) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time
Time frame: Day 1
Difference in the mean stretch velocity between the affected and unaffected upper limbs
Comparison of the mean stretch velocity (in meters per second, m/s) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time
Time frame: Day 1
Difference in the maximum resistance force between the affected and unaffected upper limbs
Comparison of the maximum resistance force measured by the dynamometer (in Newtons) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time
Time frame: Day 1
Difference in the mean resistance force between the affected and unaffected upper limbs
Comparison of the mean resistance force measured by the dynamometer (in Newtons) over the entire movement of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time
Time frame: Day 1
Difference in the extend of spastic resistance between the affected and unaffected upper limbs
Comparison of the extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time
Time frame: Day 1
Comparison of Instrumental and Clinical Measures of total elbow range of motion
Total elbow extension range of motion (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Measured angle (in degrees) measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale
Time frame: Day 1
Comparison of Instrumental and Clinical Measures of stretch velocity
Mean stretch velocity (in meters per second, m/s) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Stretch velocity categorized as slow, medium or fast, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale
Time frame: Day 1
Comparison of Instrumental Resistance Force and Clinical Spasticity Assessment
Mean resistance force measured by the dynamometer (in Newtons) over the entire movement of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.
Time frame: Day 1
Comparison of Instrumental extend of spastic resistance and Clinical Spasticity Assessment
Extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.
Time frame: Day 1
Duration of instrumental measurement compared with Modified Tardieu Scale assessment
Comparison of the administration time required to perform the instrumental assessment using inertial sensors and a dynamometer versus the clinical assessment using the Modified Tardieu Scale. Time will be recorded in minutes and seconds.
Time frame: Day 1
Feasibility of post hoc biomechanical parameter extraction from video recordings
Feasibility of extracting biomechanical parameters from synchronized video recordings acquired during instrumental assessment using predefined image quality and joint landmark visibility criteria. Feasibility will be determined by the proportion of participants for whom video-based biomechanical analysis can be successfully performed.
Time frame: Day 1
Comparison of Video-Derived and Instrumental total range of motion
Comparison of the total elbow extension range of motion (in degrees) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).
Time frame: Day 1
Comparison of Video-Derived and Instrumental mean stretch velocity
Comparison of mean stretch velocity (in meters per second, m/s) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).
Time frame: Day 1
Comparison of Video-Derived and Instrumental maximum resistance force
Comparison of the maximum resistance force measured by the dynamometer (in Newtons) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).
Time frame: Day 1
Comparison of Video-Derived and Instrumental total range of mean resistance force
Comparison of the mean resistance force measured by the dynamometer (in Newtons) over the entire movement obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).
Time frame: Day 1
Comparison of Video-Derived and Instrumental total range of extend of spastic resistance
Comparison of the extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).
Time frame: Day 1
Comparison of Video-Derived and Clinical Measures of total range of motion
Total elbow extension range of motion (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Measured angle (in degrees) measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale
Time frame: Day 1
Comparison of Video-Derived and Clinical Measures of stretch velocity
Mean stretch velocity (in meters per second, m/s) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Stretch velocity categorized as slow, medium or fast, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale
Time frame: Day 1
Comparison of Video-Derived and Clinical Measures of extend of spastic resistance
Extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.
Time frame: Day 1
Comparison of Video-Derived and Clinical Resistance Force Measurements
Mean resistance force measured by the dynamometer (in Newtons) over the entire movement of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.
Time frame: Day 1
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Feb 2027; primary completion for Feb 2029, 24 months later.
Of 227 non-industry interventional studies with no phase under Muscle Spasticity, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 34. This study's planned 24 months is above that.
Counting every sponsor, half of 235 studies reached it within 15 months; a quarter within 7 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier →